Recent and archived press releases with clinical and research news
Findings from NIH-supported clinical trial suggest that intravenous acetaminophen has the greatest benefit in the sickest patients.
The 5,704 nautical-mile trip is the farthest VUMC has traveled for an organ. The remarkable journey illustrates how new technologies make it possible to preserve organs longer, allowing Vanderbilt to look farther for a match.
Vanderbilt University Medical Center has collaborated with Children’s National Hospital in Washington, D.C., to develop the Rare Disease Clinical Activity Protocol Program, or RareCAP, a growing online repository of clinical protocols designed to offer quick, practical guidance on the care of patients with rare diseases.
A study led by researchers from Vanderbilt-Ingram Cancer Center sheds light on some of the genetic variants that make breast cancer more deadly for women of African ancestry and significantly reduces the disparity in knowledge for assessing their genomic risk factors.
“It is important to remember,” he says, “This too shall pass.”
The approach, which combines high-performance computing, simulation, machine learning and experimental validation, will help keep antibody drugs up to date in the future against highly variable viruses.